Quantum Biopharma (QNTM) Other Operating Expenses (2019 - 2026)

Quantum Biopharma has reported Other Operating Expenses for 8 years, with the latest figure at $1.0 million in Q1 2026.

• Quarterly Other Operating Expenses rose 142.18% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 295.75% YoY) and the FY2025 annual result came in at $3.5 million, up 443.15% from the prior year.
• Other Operating Expenses grew to $1.0 million in Q1 2026 per QNTM's latest filing, from $937823.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $4.8 million in Q1 2023 and troughed at $177884.0 in Q1 2024.
• A 5-year average of $1.2 million and a median of $964395.0 in 2025 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses plunged 96.31% in 2024, then surged 512.94% in 2025.
• Over 5 years, Other Operating Expenses stood at $1.2 million in 2022, then surged by 176.86% to $3.3 million in 2023, then slumped by 94.57% to $177884.0 in 2024, then surged by 427.21% to $937823.0 in 2025, then increased by 8.71% to $1.0 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $1.0 million, $937823.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.